CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 4 Grant or award Director acquired 480,303 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 350,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 268,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award chief operating officer acquired 245,454 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 466,666 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- DEF 14C Other DEF 14C
- D Other Notice of Sales of Unregistered Securities
- SC 13D Stake Beneficial Ownership Report
- PRE 14C Other PRE 14C
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change
- 8-K/A Event New debt or obligation
- 8-K Event New debt or obligation
- 10-Q Report Quarterly Report
Page 22 of 26 · 511 filings